AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Compass Therapeutics, Inc. Director's Dealing 2018

Jul 30, 2018

32588_dirs_2018-07-30_9ff78c47-5e1d-4865-9c86-193d0e8129b1.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Olivia Ventures, Inc. (NONE)
CIK: 0001738021
Period of Report: 2018-07-29

Reporting Person: Tompkins Mark N. (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.0001	4750000	Direct